Trial Profile
A retrospective study investigated cetuximab based regimen in first-line therapy in patients with unresectable metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 15 Oct 2016 New trial record